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Interscalene Brachial Plexus Block for
Arthroscopic Shoulder Surgery
A Systematic Review
Michael S. Hughes, MD, Matthew J. Matava, MD, Rick W. Wright, MD, Robert H. Brophy, MD,
and Matthew V. Smith, MD
Investigation performed at the Department of Orthopedic Surgery, Washington University, Chesterfield, Missouri

S

houlder arthroscopy is currently one of the more common orthopaedic procedures, with an estimated 1.4
million procedures performed per year worldwide1.
Many of these procedures are being performed on an outpatient basis and present substantial postoperative pain control
challenges to the surgeon and anesthesiologist. An integral
component of successful ambulatory surgical treatment is
achieving and maintaining adequate pain management during
the early postoperative course.
The pain during the first twenty-four to forty-eight
hours after arthroscopic shoulder surgery is often equivalent
to that after open surgery, with 30% of patients reporting
severe pain on the first postoperative day2. In a study of more
than 15,000 outpatient surgical procedures from nine different surgical specialties, pain was responsible for 12% of the
unplanned postoperative hospital admissions3. A retrospective review of 222 shoulder arthroscopy cases revealed a 2%
rate of unplanned overnight admission because of pain symptoms4. Additionally, postoperative pain may instigate endocrine
and metabolic responses, autonomic reflexes, nausea, and
constipation that potentially lead to delayed postoperative
rehabilitation, adhesive capsulitis, hospital admission, and
loss of work days5-7. As a result, many different modalities
have been described in both the orthopaedic and anesthesiology literature to minimize postoperative pain following
ambulatory surgery8.
Traditionally, these surgical procedures were performed
under general anesthesia with infiltration of local anesthetic
and parenteral administration of opioids to achieve early
postoperative pain relief. Over forty years ago, Winnie reported the results of an interscalene brachial plexus block
involving a single anesthetic injection for pain control fol-

lowing shoulder surgery9. Nearly two decades later, Tuominen
et al. described an interscalene block technique involving the
placement of an indwelling catheter to provide continuous
infusion of anesthetic for two to three days of pain relief 10. A
third modality includes continuous anesthetic administration
via a pump catheter placed into the subacromial or intraarticular space11-13.
There is a relative paucity of high-level randomized
controlled studies addressing the benefits and potential complications associated specifically with interscalene brachial
plexus blocks. The purpose of the present systematic review
was to evaluate the available Level-I and II randomized
controlled trials comparing interscalene blocks in arthroscopic shoulder surgery with placebo or noncontinuous
infusion of anesthetic, with the primary outcome being analgesic efficacy. Secondary outcomes included use of narcotic
and non-narcotic medication, side effects of opioid use, costeffectiveness, and complications of the interscalene block.
We hypothesized that the interscalene block would be at least
as effective as general anesthesia alone or other regional anesthetic techniques for decreasing postoperative pain, the
need for supplemental analgesics, and episodes of nausea and
vomiting, and that the associated complication rate would
be low.
Materials and Methods

W

e performed an electronic search of PubMed (1950 to present), Embase
(1966 to present), and the Cochrane databases with use of the following
search terms: ‘‘shoulder arthroscop* AND (block OR regional anesthesia),’’
‘‘rotator cuff AND (block OR regional anesthesia),’’ and ‘‘interscalene.’’ This
search was performed on May 28, 2012, and identified 1049 articles in PubMed,
1630 articles in Embase, and no articles in the Cochrane library database. The
search results represented a total of 1350 unique articles after removal of
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duplicates. The abstracts of these articles were reviewed for inclusion in the
systematic review. Thirty-five of the articles subsequently underwent full-text
review, and ten were ultimately found to satisfy the inclusion and exclusion
criteria. The systematic review included published Level-I or II randomized
controlled trials analyzing the effectiveness of interscalene brachial plexus
blockade for shoulder arthroscopy procedures, assessed on the basis of pain
relief and/or usage of narcotic medication, compared with either placebo or
noncontinuous infusion of anesthetic via a pump. Non-English-language articles, abstracts, proceedings from meetings, and studies that included open
shoulder procedures, surgical procedures on other parts of the upper extremity,
or a continuous subacromial or intra-articular pump analgesic modality were
excluded. Two authors (M.S.H. and M.V.S.) independently executed the search
protocol to identify studies for inclusion, evaluate homogeneity, and appraise
study quality.
The bibliographies of the ten eligible articles and a manual review
of articles published between January 2012 and June 2012 in Acta Anaesthesiologica Scandinavica, Anesthesia & Analgesia, Arthroscopy, The
American Journal of Sports Medicine, European Journal of Anesthesiology,
The Journal of Bone and Joint Surgery (American and British Volumes),
Journal of Shoulder and Elbow Surgery, and Regional Anesthesia and Pain
Medicine did not identify any additional articles for inclusion. Thus, ten
studies were included in the final analysis. The CONSORT (Consolidated
Standards of Reporting Trials) guidelines were used to help evaluate study
14
quality .

Source of Funding
There was no external funding source for this study.

Results
ables I and II summarize the study demographics, including the outcome measures used and potential sources
of bias. Table III summarizes the study randomization and
blinding process and power analysis. Table IV summarizes the
analgesia protocols, which included oral and parenteral administration of narcotics and non-narcotics and local infiltration of anesthetics. A meta-analysis was not believed to be
appropriate because of the wide variations in the nature of the
control and treatment groups across the studies and the heterogeneity of the outcome measures used.
Use of an interscalene block was associated with a
significant reduction in the pain level, as measured with use
of a visual analog scale (VAS) or a visual eleven-point box
scale (BS-11), at various time points up to twenty-four hours
after surgery in each of the ten studies included in the systematic review15-24. VAS and BS-11 pain scores were significantly lower than those in the controls at twenty-four hours
after surgery in three of the seven studies that included this
time point17,21,24. Lee et al. and Nisar et al. reported significantly lower VAS scores at all time points less than twelve
hours after surgery but not at twenty-four hours20,22. Oh et al.
reported lower VAS scores at one hour and eight hours after
surgery in the group that received a single-injection interscalene block compared with the control group that received
intravenous pain medication23. Laurila et al. found that use of
an interscalene block significantly lowered the BS-11 score at
rest during the first four hours after surgery as well as the
score when the patient moved the arm during the first six
hours19. DeMarco et al. conducted a double-blind study of
fifty-three patients who received a subacromial continuous
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infusion of bupivacaine combined with an interscalene injection
of either 0.5% ropivacaine or a saline solution control. The VAS
score in the patients who received the ropivacaine interscalene
block was significantly lower during the first six hours but not at
subsequent time points (up to eighty hours)16.
In addition, the amount of supplemental analgesia required was significantly less in the interscalene block group
compared with the control group at various postoperative
time points in eight of the nine studies that examined this
outcome15,17,19-24. The type of supplemental analgesia varied
across the studies. Only the study by Gonano et al. did not
record the administration of supplemental medication in the
treatment and control groups18. It should be noted that both
the VAS and supplemental analgesic outcomes could be susceptible to subject bias as the patients in most of the studies
were aware of whether they had received an interscalene block
or another form of treatment. Only the studies by Al-Kaisy
et al. and DeMarco et al. had true double-blinding between
the control and treatment groups15,16. In both of those studies,
the VAS score was approximately 50% lower in the group that
received an interscalene block with anesthetic compared with
the group that received saline solution. In the study by Al-Kaisy
et al., the amount of supplemental analgesia needed was approximately one-third as great in the group that received an
interscalene block with anesthetic compared with the group that
received saline solution15. The study by DeMarco et al. revealed a
trend toward lower oral narcotic usage in the interscalene block
group, although the difference did not reach significance16.
One of the proposed benefits of regional anesthesia is a
decrease in systemic complications such as nausea and vomiting.
The prevalence of nausea and vomiting was reported in eight of
the ten studies included in this review15,17,19-24. Only two of the
eight studies revealed a significant difference between the interscalene block and control groups, with less nausea and vomiting
reported in the interscalene block group in each case15,24. It is
possible that the remaining six studies failed to reveal a significant
difference because of a type-II sampling error, as each of the
studies that included a power analysis was designed to achieve
adequate power for the VAS score or supplemental analgesic
usage rather than the prevalence of nausea and vomiting.
The overall complication rate attributable to the interscalene block was low. Horner syndrome was noted in six patients
in the included studies, with five of these being in one study18,21.
Only one hematoma was reported21, and one case of persistent
hand paresthesia resolved after twenty-four hours15. Four cases of
mild dyspnea and two cases of dysphonia were noted in the interscalene block group in one study17. A potential observer bias for
these blinded-evaluator studies resulted from the inability of the
evaluator to definitively determine failure or success of the block as
the allocation group was not known at the time of the evaluation.
Discussion
his systematic review was performed to analyze the available evidence from high-quality studies in order to evaluate our hypothesis that an interscalene block was at least as
effective as general anesthesia alone or other regional anesthetic
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TABLE I Study Treatment Demographics*

Study

Surgery†
15

Al-Kaisy et al.

Treatment Group‡

Treatment Injection
Solution§

SAD, RCR, cap

ISBP

0.125% bupi with 1:400,000 epi (10 mL)

SAD, RCR, biceps
tenotomy, SLAP, DCE

ISBP

0.5% ropi ( 30 mL)

17

SAD, RCR, debridement

(1) ISBP,
(2) subacromial preop.,
(3) intra-articular preop.,
(4) subacromial 1
intra-articular preop.

0.5% levo with 1:200,000 epi (30 mL)

18

NM, shoulder arthroscopy

ISBP

0.75% ropi (20 mL)

Debridement, labral, RCR, SAD

(1) ISBP, (2) subacromial
bursal injection

(1) 0.5% ropi (15 mL), (2) 0.5% ropi (15 mL)

RCR

ISBP

0.5% ropi (10 mL)

SAD

(1) ISBP, (2) IV PCA

(1) 0.5% bupi (1.25 mg/kg of a 5 mg/ml solution),
(2) 1 mg morphine every 6 min

SAD, DCE, clavicle coplaning

(1) ISBP, (2) subacromial
bursal injection

(1) 0.5% bupi (20 mL), (2) 0.5% bupi (10 mL)
and 1% pril (20 mL)

RCR, SLAP, labral

(1) ISBP 1 IV PCA,
(2) intra-articular pump,
(3) ISBP 1 intra-articular pump

(1) 0.25% ropi (20 mL) 1 fentanyl, ketorolac,
ondansetron on PCA,
(2) 0.75% ropi (10 mL) and 0.5% ropi
(96 mL) infused at 2 mL/hr,
(3) 0.25% ropi (20 mL) and 0.75% ropi
(96 mL) infused at 2 mL/hr

SAD

(1) Suprascapular nerve block,
(2) intra-articular injection,
(3) ISBP

(1) 0.25% bupi (10 mL) with 1:200,000 epi,
(2) 0.25% bupi (20 mL) with 1:200,000 epi,
(3) 0.25% bupi (20 mL) with 1:200,000 epi

16

DeMarco et al.
Fontana et al.

Gonano et al.

19

Laurila et al.
20

Lee et al.

21

Lehtipalo et al.
22

Nisar et al.
23

Oh et al.

24

Singelyn et al.

*IV = intravenous, PCA = patient-controlled analgesia, and VAS = visual analog pain scale. †SAD = subacromial decompression, RCR = rotator
cuff repair, cap = capsulorraphy, SLAP = repair of SLAP (superior labrum anterior and posterior) tear, DCE = distal clavicular excision, and NM = not
mentioned. ‡ISBP = interscalene brachial plexus block. §Bupi = bupivacaine, epi = epinephrine, ropi = ropivacaine, levo = levobupivacaine, and
pril = prilocaine.

techniques in decreasing postoperative pain, the need for
supplemental analgesics, and episodes of nausea and vomiting.
Additionally, we attempted to document the prevalence of
complications associated with the interscalene block. Our
evaluation of the available Level-I and II evidence indicates that
use of an interscalene block in shoulder arthroscopy resulted in
a significant reduction in the pain level and the need for supplemental analgesics compared with general anesthesia and
other regional anesthetic techniques. Nausea and vomiting may
have been reduced by the interscalene block in two studies,
but the remaining six studies did not support this claim. There
were relatively few reported complications in the included
studies, and most of these complications were transient.
An interscalene block can be performed by means of a
single injection of anesthetic or by placement of an indwelling
catheter and anesthetic pump. We decided to limit this review
to include only comparisons between an interscalene block
and a placebo or noncontinuous infusion of anesthetic for two
reasons: (1) interscalene blocks are one of the most common
regional anesthesia techniques utilized, and (2) such a restriction limits the heterogeneity of the interventions reviewed25.

We also decided to exclude studies that utilized intra-articular
anesthetic delivery devices as use of such devices has been associated with the development of glenohumeral joint chondrolysis
after arthroscopy26-28.
This review did not include articles that compared a
single-injection interscalene block with a continuous interscalene block. However, such a comparison has been made in
a randomized study by Fredrickson et al. involving sixty-one
patients undergoing subacromial decompression, distal clavicular excision, or labral repair. Patients were randomized by
computer to either an intraoperative interscalene block with
0.5% ropivacaine or a continuous interscalene block for a total
of forty-eight hours. Those authors found that the continuous
interscalene block resulted in significantly lower levels of pain
and supplemental analgesic usage during the first postoperative
day compared with the single-injection interscalene block29.
An identified weakness of this systematic review is the
heterogeneity in the preoperative and postoperative protocols and
in the shoulder pathology that was being treated. None of the ten
studies exactly matched another study with regard to the anesthetic medication, medication concentration, or volume infused.
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TABLE I (continued)
Control Injection
Solution§

Control Group‡

Continuous Infusion
(Duration)

No. of Patients in
Control Group

No. of Patients in
Treatment Group

ISBP

Saline (10 mL)

No

15

15

ISBP

Saline (10 mL)

Yes (2 day)

25

28

No

20

(1) 20, (2) 21, (3) 19, (4) 23

No intervention

—

General anesthesia

—

No

20

20

Subacromial bursal
injection

Saline (15 mL)

No

15

(1) 15, (2) 15

ISBP

Saline (10 mL)

No

25

25

IV bolus

Morphine (2 mg if VAS > 3)

Yes (24 hr)

10

(1) 10, (2) 10

No

15

(1) 19, (2) 19

Yes for intra-articular
pump only (48 hr)

21

(1) 20, (2) 20, (3) 21

No

30

(1) 30, (2) 30, (3) 30

No intervention
IV PCA

—
Weight-based protocol of
0.3-0.5 mg/kg fentanyl,
0.03 mg/kg ketorolac, and
0.08 mg ondansetron
infused at 1 mL/hr

No intervention

—

TABLE II Study Outcome Demographics*

Study
15

Al-Kaisy et al.

16

DeMarco et al.

Follow-up

Pain Outcome
Measure

Medication
Outcome
Measure

24 hr

Verbal analog scale

Yes

Discharge readiness, nausea, time to first narcotic,
time to discharge, readmission, patient satisfaction

Other Outcome Measures

48 hr

VAS

Yes

Supplemental medication

17

24 hr

VAS

Yes

Patient satisfaction, nausea

18

24 hr

VAS

Yes

Nausea, time from PACU to discharge, total
cost per case

20 hr

Visual 11-point box
scale (BS-11)

Yes

Time to first PCA bolus, hourly oxycodone consumption,
nausea, satisfaction scale, vital signs

24 hr

VAS

Yes

Blood pressure, pulse, nausea

24 hr

VAS

Yes

Headache, nausea

24 hr

VAS

Yes

Nausea sickness score, time spent in hospital, time to
first bolus of morphine, sedation score

48 hr

VAS

Yes

Nausea, urinary retention, dizziness

24 hr

VAS

Yes

Patient satisfaction, nausea

Fontana et al.
Gonano et al.

19

Laurila et al.
20

Lee et al.

21

Lehtipalo et al.
22

Nisar et al.
23

Oh et al.

24

Singelyn et al.

*VAS = visual analog pain scale, PACU = post-anesthesia care unit, and PCA = patient-controlled anesthesia.
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TABLE III Study Statistics*
Study

Randomization
15

Al-Kaisy et al.

Blinding

Power Analysis

Bias

Computer

Yes: observer
& patient

NM

Prevalence of failed block unknown
because no function assessment
prior to surgery

Computer

Yes: observer
& patient

Sample size of 25 patients
needed for 30% difference
in VAS pain score and 50%
difference in narcotic tablet
use

Transfer or exclusion bias as
6 patients disqualified for
nonfunctional subacromial
pain pump

17

Computer

Yes: observer
only

Clinical difference of
1.5 boluses with SD of
0.5. Sample size of 24
patients for each group
provided 5% alpha level
and 80% power

Subject bias as patients were not
blinded to their group allocation, and
type-II error as group sizes were less
than called for by the power analysis.
Exclusion or transfer bias as 17 patients
were excluded post hoc because their
VAS pain score would ‘‘notably alter
the evaluation’’

18

Sealed envelope

Yes: observer
only

25% difference in cost
in euros (difference, 10k;
within-group SD, 10k).
Sample size of 20

Selection bias as no mention of shoulder
arthroscopy procedures and sealed
envelope randomization; subject bias
as patients were not blinded to their
group allocation

Sealed envelope

Yes: observer
and subacromial
bursa
group only

50% difference in mean
oxycodone consumption
in the SUB and ISBP groups
compared with the
placebo group during
the first 6 hr postop.

Selection bias as sealed envelope
randomization; subject bias
as patients were not blinded
to their group allocation

Random number
table

Yes

NM

Anesthesiologist/surgeon
not blinded to treatment
group allocation

NM

Yes: observer
only

NM

Randomization process not
described. Subject bias due to
presence of a continuous ISBP,
PCA, or IV boluses. Randomization
resulted in an uneven distribution
between male and female
patients among groups. 30%
of the ISBP patients
had a ‘‘visually obvious
dislocation of the plexus
catheter’’

Computer

Yes: observer
only

1 SD difference in PCA
consumption between
the 2 treatment groups.
Sample size of 17 patients

Subject bias

NM

Yes: observer
only

NM

Subject bias as patients were
not blinded to their group allocation;
selection bias as the randomization
process was not described

Computer

Yes: observer
only

50% difference in VAS with
25 in ISBP group and 50
in control group with SD of 15

Subject bias as patients as patients
were not blinded to their group
allocation since controls
received no placebo injection

16

DeMarco et al.

Fontana et al.

Gonano et al.

19

Laurila et al.

20

Lee et al.

21

Lehtipalo et al.

22

Nisar et al.

23

Oh et al.

24

Singelyn et al.

*NM = not mentioned, VAS = visual analog scale, SD = standard deviation, ISBP = interscalene brachial plexus block, SUB = subacromial bursa
blockade, PCA = patient-controlled analgesia, and IV = intravenous.
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TABLE IV Study Analgesia Protocol*

Study

Narcotic,
IV/IM/Subq.

Anesthesia Type
15

Al-Kaisy et al.

16

DeMarco et al.

Other,
IV/IM/Subq.

General

Morph

NM

General

NM

NM

17

General

Fentanyl PCA

NM

18

General or ISBP

Piritramid

Acetaminophen

General

Oxycodone

Oxycodone

General

NM

Tramadol

General

Morphine

none

General

Morphine PCA

NM

General

Meperidine

Ketorolac

General

Morphine

NM

Fontana et al.
Gonano et al.

19

Laurila et al.
20

Lee et al.

21

Lehtipalo et al.
22

Nisar et al.
23

Oh et al.

24

Singelyn et al.

*IV = intravenous, IM = intramuscular, subq. = subcutaneous, NM = not mentioned, bupi = bupivacaine, ISBP = interscalene brachial plexus
block, and PCA = patient-controlled analgesia.

TABLE IV (continued)

Narcotic, Oral

Other, Oral

Subacromial Injection

Intra-articular
Injection

Local Anesthetic
to Incision

Tylenol 3

Toradol

NM

NM

NM

Percocet

NM

Subacromial pump 5-mL priming
bolus of 0.5% bupi followed by 0.5%
bupi at 2 mL/hr for 72 hr

NM

NM

NM

NM

NM

NM

NM

NM

NM

NM

NM

NM

NM

Ketoprofen

NM

NM

NM

NM

NM

NM

NM

NM

NM

NM

NM

NM

NM

Paracetamol, codeine

Diclofenac

NM

NM

NM

NM

NM

NM

NM

NM

Propacetamol

NM

NM

NM

NM

Fortunately, the interscalene block in all ten studies was performed
with use of a neurostimulator for guidance, thus avoiding a further
source of heterogeneity; however, the use of ultrasonographically
guided interscalene blocks is becoming increasingly popular30,31.
Finally, a power analysis was not mentioned as a part of the
design of four of the ten studies in this review. The remaining six
studies that did include a power analysis varied with regard to the
variable on which the power analysis was based16-19,22,24. This
heterogeneity introduces the potential for type-II (beta) errors
for variables for which no statistically significant difference was
found (i.e., the need for supplemental medication 16 and the
occurrence of nausea17,19-23).
Since arthroscopic shoulder procedures are now often
performed on an outpatient basis, interventions such as regional

anesthesia, which decrease postoperative pain as well as nausea
and vomiting and have a low complication rate32-36, can potentially decrease the need for unexpected hospital admission, unwanted medical complications related to surgery, and overall
health-care costs. Use of an interscalene block can also increase
patient satisfaction after arthroscopic shoulder surgery15,17,24.
Lastly, Gonano et al. found that use of an interscalene block for
patients undergoing arthroscopic shoulder surgery reduced total
costs, improved the anesthesia-related work flow, decreased the
time spent in the post-anesthesia care unit, and decreased the
time spent in the operating room18. These factors will become
more important with the implementation of performance
benchmarks as part of the Patient Protection and Affordable
Care Act37.
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In conclusion, use of an interscalene brachial plexus
block resulted in significant decreases in postoperative pain
scores and in the amount of supplemental analgesia required
in patients undergoing arthroscopic procedures involving the
shoulder. The interscalene block had no clear benefit with regard to decreasing nausea. The overall complication rate attributable to the block was negligible. Interscalene brachial
plexus blocks were cost-effective compared with general anesthesia alone. n
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